Do FTO, TMEM18, and LEPR risk variants raise OSA risk by increasing adiposity?

The association between specific genetic variants—FTO rs9939609, TMEM18 rs6548238, and LEPR rs1137101—and an increased risk for higher adiposity is well-established. This elevated adiposity serves as a primary causal driver for the development and progression of obstructive sleep apnea (OSA).

Genetic influence on adiposity

Research confirms that these specific single nucleotide polymorphisms (SNPs) are significant risk alleles for increased BMI and obesity:

• FTO rs9939609 (AA): This is the most robustly studied obesity-related variant. Meta-analyses involving over 160,000 individuals show it consistently increases BMI and obesity risk (OR 1.31), primarily by modulating appetite control and energy balance.
• TMEM18 rs6548238 (CT): Large-scale cohort data (e.g., the Add Health study) demonstrate a significant association with BMI changes over time. TMEM18 is highly expressed in the hypothalamus, which is the brain's regulatory center for feeding behavior.
• LEPR rs1137101 (AG): This variant in the leptin receptor gene is linked to metabolic dysfunction and higher obesity risk. Studies in diverse populations have shown effect sizes ranging from 0.239 to 0.31 kg/m² per risk allele.

Mechanisms of airway collapsibility

Increased adiposity directly impacts the structural integrity of the upper airway during sleep through several physiological pathways:

• Mechanical Loading: Adipose tissue accumulates in the tongue, soft palate, and parapharyngeal fat pads. This narrows the airway and increases "pharyngeal critical pressure" (Pcrit), making the airway more prone to collapse under negative pressure.
• Reduced Caudal Traction: Obesity reduces functional residual capacity (lung volume). In healthy individuals, lung expansion provides longitudinal tension that stabilizes the airway; the loss of this tension in those with higher adiposity increases passive collapsibility.
• Metabolic and Neuromuscular Impact: Adiposity is linked to impaired neuromuscular control of the airway. Leptin-mediated dysfunction may also reduce the tonic muscle activity required to keep the airway open.

Clinical significance for OSA

Mendelian randomization studies using these genetic markers confirm that higher genetically predicted BMI significantly increases OSA risk (OR 1.93). The relationship is dose-dependent and bidirectional: while a 20% reduction in BMI correlates with a 57% reduction in the Apnea-Hypopnea Index (AHI), OSA itself can exacerbate adiposity by disrupting metabolic hormones.

Bottom line

The presence of FTO, TMEM18, and LEPR risk variants increases the genetic predisposition for higher adiposity, which subsequently increases the risk and severity of OSA by mechanically narrowing the upper airway and reducing the stabilizing forces that prevent its collapse.